ANK peptide

ANK peptide is a novel peptide designed based on the conserved residue of a single-anchored protein motif. It acts as an inhibitor of γ-synuclein (SNCG) by binding to SNCG, thereby competing with and disrupting the SNCG-BubR1 interaction. This action enhances the sensitivity of breast cancer cells to antimicrotubule agents such as nocodazole and paclitaxel. ANK peptide is useful for tumor research.

[C@@H](CC1=CN=CN1)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@H](CCCCN)N)=O)=O)CC(N)=O)=O)CO)=O)C)=O)CC(C)C)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC2=CN=CN2)C(NCC(N[C@@H](CC3=CN=CN3)C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC4=CC=C(O)C=C4)C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC5=CN=CN5)C(NCC(O)=O)=O)=O)CC(N)=O)=O)CCC(N)=O)=O)CCSC)=O)[C@@H](C)O)=O)C(C)C)=O)CC(N)=O)=O)C)=O)=O)=O)CCCNC(=N)N)=O)C(C)C)=O)CC(C)C)=O)[C@@H](C)O)=O)CCC(N)=O)=O)[C@H](CC)C)=O)CS)=O)=O)CC(C)C)=O)=O)=O)=O)CCC(N)=O)=O)CO)=O)C)=O)C(C)C)=O